DUARTE, California—/PRNewswire/—Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products, today announced the U.S. Food and Drug Administration (FDA) has approved Surgifort® human milk fortifier (human, pasteurized) for...
• Dr. Petri Vainio to become Executive Chairman • Dr. Evis Hursever to become CEO • Scott Barry to become COO • Marty Sutter to become Founding Partner New York, NY – EW Healthcare Partners, a trans-Atlantic healthcare private equity firm, today announced that it has...
London, United Kingdom –– Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capabilities of the company in the US and to continue investing further in infrastructure. Advanced...
Employee Feedback Highlights Company’s Commitment to Workplace Culture and Leadership MIAMI,FL—BioTissue, a leader in regenerative healing, using cryopreserved human birth tissue products for ocular surface disease, chronic wounds, and musculoskeletal conditions, has...
EW Healthcare Partners is deeply saddened that our esteemed colleague, Olivier Bohuon, has passed away after a long illness. The entire EW Healthcare Partners partnership mourns his untimely passing and extends our deepest condolences to his family, friends, and...
ORMOND BEACH, FL and GERMANTOWN, MD —— Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic...
Ormond Beach, Florida – Germfree announces the appointments of Dorothy Puhy, Karen Flynn, Kerry Ingalls and Helga Salling as independent non-executive members of its Board of Directors. “We are excited to welcome Dorothy, Karen, Kerry and Helga to our Board of...
LONDON, England—(Newswire.com)—EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Développement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c....
New funding to accelerate company’s strong commercial momentum SAN JOSE, California—(BUSINESS WIRE)—VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30...
